EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Elevance Health's enterprise value is €72,441 Mil.
Elevance Health's EBITDA for the trailing twelve months (TTM) ended in Jun. 2025 was €8,950 Mil. Therefore, Elevance Health's EV-to-EBITDA for today is 8.09.
The historical rank and industry rank for Elevance Health's EV-to-EBITDA or its related term are showing as below:
FRA:A58'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 7.48 Med: 11.7 Max: 15.38
Current: 8.52
During the past 13 years, the highest EV-to-EBITDA of Elevance Health was 15.38. The lowest was 7.48. And the median was 11.70.
FRA:A58's EV-to-EBITDA is ranked better than 50% of 16
companies
in the Healthcare Plans industry
Industry Median: 8.565
vs FRA:A58: 8.52
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
Elevance Health EV-to-EBITDA Historical Data
The historical data trend for Elevance Health's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Elevance Health's EV-to-EBITDA
For the Healthcare Plans subindustry, Elevance Health's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Elevance Health's EV-to-EBITDA Distribution in the Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, Elevance Health's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Elevance Health's EV-to-EBITDA falls into.
Elevance Health's current Enterprise Value is €72,441 Mil.
Elevance Health's EBITDA for the trailing twelve months (TTM) ended in Jun. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €8,950 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Elevance Health (FRA:A58) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Elevance Health's PE Ratio (TTM) for today is calculated as:
Elevance Health's share price for today is €239.10.
Elevance Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €21.239.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
Thank you for viewing the detailed overview of Elevance Health's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 46 million medical members as of December 2024. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FRA:A58 has been successfully added to your 